Successful use of the Molecular Adsorbent Recirculating System (MARS) in a patient with primary biliary cirrhosis (PBC) and treatment refractory pruritus

Hepatology Research

Volumn 25, Issue 4, 2003, Pages 442-446

  Mullhaupt, Beat ^a   Kullak Ublick, Gerd A ^a   Ambühl, Patrice M ^a   Stocker, Reto ^a   Renner, Eberhard L ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Albumin enriched dialysate; Dialysis; Extracorporeal device; Liver Failure

Indexed keywords

ALBUMIN; CALCIUM;

ADULT; ARTICLE; CASE REPORT; DIALYSATE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEMODIALYSIS; HOSPITAL ADMISSION; HUMAN; HYDROPHOBICITY; HYPERCALCEMIA; HYPOTHESIS; INTRAHEPATIC CHOLESTASIS; LIVER BIOPSY; LIVER FAILURE; LIVER TRANSPLANTATION; LONG TERM CARE; MEDICAL ASSESSMENT; METABOLITE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROTEIN BINDING; PRURITUS; QUALITY OF LIFE; SAFETY; SCORING SYSTEM; TREATMENT OUTCOME;

EID: 0037398948     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6346(02)00310-8     Document Type: Article

References (21)

1. Javitt NB. Letter: timing of cholestyramine doses in cholestatic liver disease. New Engl J Med 1974;290:1328-9.
2. Ghent CN, Carruthers SG. Treatment of pruritus in primary biliary cirrhosis with rifampin. Results of a double-blind, crossover, randomized trial. Gastroenterology 1988;94:488-93.
3. Bergasa NV, Alling DW, Talbot TL, et al. Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial. Ann Intern Med 1995;123:161-7.
4. Bergasa NV, Talbot TL, Alling DW, et al. A controlled trial of naloxone infusions for the pruritus of chronic cholestasis. Gastroenterology 1992;102:544-9.
5. Schworer H, Hartmann H, Ramadori G. Relief of cholestatic pruritus by a novel class of drugs: 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists: effectiveness of ondansetron. Pain 1995;61:33-7.
6. Schworer H, Ramadori G. Improvement of cholestatic pruritus by ondansetron. Lancet 1993;341:1277.
7. Raderer M, Muller C, Scheithauer W. Ondansetron for pruritus due to cholestasis. New Engl J Med 1994;330:1540.
8. Muller C, Pongratz S, Pidlich J, et al. Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron: a randomized, placebo-controlled, double-blind cross-over trial. Eur J Gastroenterol Hepatol 1998;10:865-70.
9. Wolfhagen FH, Sternieri E, Hop WC, Vitale G, Bertolotti M, Van Buuren HR. Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study. Gastroenterology 1997;113:1264-9.
10. Cerio R, Murphy GM, Sladen GE, MacDonald DM. A combination of phototherapy and cholestyramine for the relief of pruritus in primary biliary cirrhosis. Br J Dermatol 1987;116:265-7.
11. Cohen LB, Ambinder EP, Wolke AM, Field SP, Schaffner F. Role of plasmapheresis in primary biliary cirrhosis. Gut 1985;26:291-4.
12. Lauterburg BH, Taswell HF, Pineda AA, Dickson ER, Burgstaler EA, Carlson GL. Treatment of pruritus of cholestasis by plasma perfusion through USP-charcoal-coated glass beads. Lancet 1980;2:53-5.
13. Ng VL, Ryckman FC, Porta G, et al. Long-term outcome after partial external biliary diversion for intractable pruritus in patients with intrahepatic cholestasis. J Pediatr Gastroenterol Nutr 2000;30:152-6.
14. Stange J, Mitzner SR, Risler T, et al. Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support. Artif Organs 1999;23:319-30.
15. Stange J, Mitzner S. A carrier-mediated transport of toxins in a hybrid membrane. Safety barrier between a patients blood and bioartifical liver. Int J Artif Organs 1996;19:677-91.
16. Stange J, Mitzner S, Ramlow W, Gliesche T, Hickstein H, Schmidt R. Dialysis against a recycled albumin solution enables the removal of albumin-bound toxins. ASAIO J 1993;39:621-5.
17. Rydning A, Schrumpf E, Abdelnoor M, Elgjo K, Jenssen E. Factors of prognostic importance in primary biliary cirrhosis. Scand J Gastroenterol 1990;25:119-26.
18. Mahl TC, Shockcor W, Boyer JL. Primary biliary cirrhosis: survival of a large cohort of symptomatic and asymptomatic patients followed for 24 years. J Hepatol 1994;20:707-13.
19. Freedman MR, Holzbach RT, Ferguson DR. Pruritus in cholestasis: no direct causative role for bile acid retention. Am J Med 1981;70:1011-6.
20. Jones EA, Bergasa NV. The pruritus of cholestasis. Hepatology 1999;29:1003-36.
21. Mitzner SR, Stange J, Klammt S, Peszynski P, Schmidt R, Noldge-Schomburg G. Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure. J Am Soc Nephrol 2001;12:S75-82.